Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Abnormal LFTs – Practical Cases Expert Q&A

MRAs for Heart Failure Update - New Developments

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

Practical Strategies to Increase Vaccination Rates This Flu Season

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne